More activity, fewer drugs by Sobieszczańska, Małgorzata
EDITORIAL
Cardiology Journal
2007, Vol. 14, No. 3, pp. 220223
Copyright ' 2007 Via Medica
ISSN 18975593
220 www.cardiologyjournal.org
Address for correspondence:
Ma‡gorzata Sobieszczaæska, MD, PhD
Department of Pathophysiology, Wroclaw Medical University
Marcinkowskiego 1, 50368 Wroc‡aw, Poland
e-mail: malsobie@poczta.onet.pl
More activity, fewer drugs
Ma‡gorzata Sobieszczaæska
Department of Pathophysiology, Wroclaw Medical University, Wroc‡aw, Poland
Article p. 260
The subject of the paper by Bacharova et al. [1]
is of great interest, because it constitutes an impor-
tant contribution to the very topical discussion about
the low levels of physical activity in the general pop-
ulation, not only among the elderly and middle-aged
but also among children and teenagers, which makes
the prognosis for the future worse.
The problem of sedentary life-styles, closely
linked to obesity, arterial hypertension, dyslipidemia
and hyperinsulinemia, is becoming ever more seri-
ous. These traits are, in turn, well-known modifia-
ble risk factors of metabolic syndrome X, diabetes
mellitus type II and cardiovascular disease, which in
consequence further affect overall mortality. For
instance, in the year 2000 cardiovascular disease was
a cause of 16.7 million deaths worldwide [2].
Interestingly, it was shown that a reduction in
the influence of risk factors results in a more effec-
tive decrease in cardiovascular mortality than ad-
vances in the diagnostics and therapy of this dis-
ease [3]. The INTERHEART Study in 52 countries
revealed that six risk factors, namely hyperlipi-
demia, smoking, hypertension, diabetes, visceral
fatness and psychosocial factors, in combination
with three cardioprotective factors, these being fruit
and vegetable consumption, low doses of alcohol and
regular physical exercise, determined over 90% of
myocardial infarction morbidity [4].
It has now been demonstrated beyond doubt by,
for example, the pioneer epidemiological studies on
the Framingham cohort that atherosclerotic cardi-
ovascular disease is to a great extent a product of
a faulty life-style [5]. A harmful modern life-style
was for decades typical mainly of Western societies,
the members of which were said to eat too much
of a too rich diet, exercise too little, grow fat and
smoke too much, as stated in 1970 by the Interso-
ciety Commission for Heart Disease Resources [6].
Unfortunately, in recent years these bad habits of
civilisation have quickly spread to the developing
countries too. According to the epidemiological prog-
nosis, by 2020, owing  simply to the share of the
developing countries, ischemic heart disease will
become the main cause of death in the world [7].
What makes the situation worse is that the
youngest section of the population is also in real
danger of incurring many of the severe conditions
resulting from an unhealthy life-style. Because of
the hold exerted by TV and PCs energy expendi-
ture per day is currently 600 kcal less than it was
in children 50 years ago [8]. The number of obese
children is constantly growing worldwide, and this
is caused by overeating, junk food and a sedentary
life-style. This increases the risk of metabolic syn-
drome X, related pathogenetically with diabetes
mellitus II and cardiovascular disease [9]. Up to 60%
of obese children aged 510 years manifest one
additional risk factor for cardiovascular disease,
such as hyperlipidemia, hypertension or hyperin-
sulinemia, and in 25% of them two or more risk fac-
tors are identified [10].
It has, on the other hand, been ascertained
that there is a clear correlation between childrens
levels of physical activity and the significance of many
risk factors, such as fat body mass, body mass index,
total cholesterol, triglicerides, apolipoprotein B,
insulin and blood pressure [11, 12].
It is 20 years since Kannel et al. [5] made the
suggestion that intensity of physical activity is an
important ingredient in a multifactorial cardiovas-
cular risk profile, which not only modifies positive-
ly the other atherosclerosis risk factors, but main-
tains the integrity of the cardiovascular system. Ten
years later, lack of physical activity, with special
stress on recreational activity during leisure time,
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was commonly accepted as one of the major inde-
pendent risk factors of cardiovascular disease [13].
It has been reliably documented that systemat-
ic and long-term physical training, especially endur-
ance one, leads to may positive cardiovasoprotective
changes [14]. These changes include the physiolog-
ical adaptation of the cardiovascular system, an in-
crease in general physical capacity and alterations
to modifiable risk factors. With respect to this, it
has been found that physical training can lower
systolic and diastolic blood pressure [15]. Further-
more, even moderate exercise causes a significant
reduction in serum levels of total cholesterol,
LDL-cholesterol and triglicerides and an elevation
of HDL-cholesterol [16]. It has also been demon-
strated that regular physical activity decreases
blood levels of insulin and glucose [17] and reduc-
es body mass index [18]. Endurance training shows
additional anti-atherosclerotic effects by improving
coronary endothelium function [19], lowering lev-
els of CRP [20] and homocysteine [21] as well as
prothrombotic status [22].
The findings of many long-standing epidemio-
logical projects (e.g. the Framingham Study,
MRFIT, Harvard Alumni Study and Nurses Health
Study) have revealed that regular physical activity
has an unassailable position in the prevention of
cardiovascular disease [2325] and of other condi-
tions such as arterial hypertension, diabetes melli-
tus, osteoporosis, neoplasm and depression [26]. It
has also been documented that regular physical train-
ing with an energy expenditure of 7002000 kcal per
week has resulted in a 2530% reduction in all-
cause mortality and in a 3050% reduction in the
risk of ischemic heart disease [13, 27].
The current recommendations concerning
physical activity in the primary prevention of car-
diovascular disease are as follows: endurance train-
ing lasting 2060 minutes at a moderate intensity
(4060% VO2max or 6075% HRmax) performed
a minimum of three times a week (supplemented
by resistance training a minimum of twice a week),
consuming at least 1000 kcal per week [28].
Promotion of regular physical training is incor-
porated into the three-level model of cardiovascu-
lar disease prevention which was proposed by Ben-
jamin and Smitch in 2002. In this model primary and
secondary interventions are supplemented by es-
sential prevention which embraces the entire pop-
ulation, from children to the very elderly [29].
In the context of mass prevention referred
to above, the subject of the paper Decrease in QRS
amplitude in juvenile female competitive athletes
during the initial twenty-one months of intensive
training, which concerns the adaptation of the car-
diovascular system to systematic physical exercise
performed by teenagers, is very topical. A group
consisting of junior (1317 year-old) female athletes
were subjected over 21 months to almost daily
gymnastic training comprising both endurance
(aerobic) and resistance (anaerobic) exercises.
It is known that as a result of long-term, inten-
sive, systematic and combined physical training the
heart usually develops organic changes known as
athletes heart, including enlarged ventricular
chambers (eccentric hypertrophy) in conjunction
with increased left ventricular wall thickness (con-
centric hypertrophy). The athletes heart is of-
ten associated with an increased QRS amplitude on
12-lead ECG recordings [30].
In routine medical practice a preliminary diag-
nosis of left ventricular hypertrophy (LVH) is still
based on ECG voltage criteria, which are then ver-
ified by echocardiography. ECG is regarded as re-
flecting left ventricular thickness, according to the
assumption that the greater the left ventricular
mass, the stronger the cardioelectric field and the
higher the QRS amplitude, whereas echocardiog-
raphy is to estimate the size of the left ventricle.
However, because it has been demonstrated that
QRS amplitude and left ventricular mass correlate
poorly, it is thought that ECG enables only a small
proportion of real LVH cases to be detected. Addi-
tionally, over 50% of athletes with the augmented
left ventricular mass do not manifest a QRS volt-
age exceeding the normal ECG limits [31].
The main conclusion of the paper under con-
sideration is that, surprisingly, 21-month intensive
physical training performed by young girls led to
a decrease in QRS complex voltage, which is in con-
trast to the traditional assumption for diagnosing
LVH using ECG criteria. In order to assess the QRS
voltage parameters, the authors applied the stand-
ard Sokolow-Lyon index (SLI) as well the approxi-
mated maximum spatial QRS vector magnitude
(QRSmax), which involves changes in the all three
spatial components and eliminates the problem of
the hearts location in the thorax. Differences as-
certained at the end of the follow-up period turned
out to be statistically significant: the mean value of
LSI decreased by 24%, and the QRSmax values de-
creased by over 30%. It should be emphasised that
the possible influence of somatometric parameters
and vagotonia, which could have accounted for the
diminished QRS voltage, were excluded.
Seeking a reason for the decreased QRS volt-
age observed as the result of the regular and inten-
sive physical training, the authors proposed an
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alternative to the classic hypothesis, suggesting
that the false negative ECG pattern in the evident
left ventricular hypertrophy could be attributed to
the relative voltage deficit caused by modifications
of the active and passive electrical properties of the
myocardium that occur during the initial phase of
hypertrophy.
Because of the importance of the issue dis-
cussed, the paper considered here should, in my
opinion, be treated as a preliminary report. It seems
worth increasing the number of the group followed
up in a further study (the present group of 12 girls
is too small). It could also be beneficial to collect
some information about the state of puberty of the
subjects analysed, which might yield a possible in-
sight into hormonal influence on left ventricular
mass, and about energy expenditure (in calories/
/metabolic equivalents), determining the intensity
level of physical training which could affect the
changes in left ventricular mass.
The results reported by Bacharova et al. [1] are
of a novel nature (there has only been one published
paper to report a decrease in QRS due to the early
stages of physical training), and the theoretical
background presented by the authors is completed
with an interesting concept.
There is nothing for it but to express an opti-
mistic hope that the pathomechanisms of exercise-
induced cardiovascular system modifications of pro-
tective strength will be a challenge for an increasing
number of researchers. Every attempt to encourage
people to apply a greater dose of physical activity to
everyday life should be vigorously supported. The
saying that Physical activity cannot be replaced by
any drug is still extremely relevant.
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